VR Adviser’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$56.2M Sell
2022
Q2
$43.1M Hold
2022
Q1
$61.3M Hold
2021
Q4
$51.1M Buy
2021
Q3
$36.4M Hold
2021
Q2
$44.4M Buy
2021
Q1
$30M Buy
2020
Q4
$21.4M Hold
2020
Q3
$25.1M Hold
2020
Q2
$29.9M Sell
2020
Q1
$28.7M Buy